{"id":"W4378802651","doi":"10.1200/jco.22.02200","title":"Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Seattle Children's Research Institute; Children's Hospital of Philadelphia","keywords":"Blinatumomab; Medicine; Chemotherapy; Internal medicine; Oncology; Leukemia; Surgery; Lymphoblastic Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006782419,0.000302161,0.002742722,0.0009408278,0.00004247878,0.000009686111,0.0004051553,0.000987618,0.00003279631],"category_scores_gemma":[0.005181288,0.0002195492,0.000340627,0.000877767,0.0006378512,0.0001678142,0.0002459638,0.003282137,0.00001669079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008520361,"about_ca_system_score_gemma":0.003248733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000540716,"about_ca_topic_score_gemma":0.001340854,"domain_scores_codex":[0.9928198,0.001128934,0.003999656,0.0005194629,0.0008441235,0.0006880557],"domain_scores_gemma":[0.9932774,0.002872912,0.002519812,0.000362131,0.0003288638,0.0006388946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4132974,0.01629929,0.5319235,0.0001130896,0.0003663056,0.004015955,0.0004923439,0.00003055102,0.00004052675,0.000009806147,0.003005026,0.03040628],"study_design_scores_gemma":[0.4877348,0.05146634,0.4571171,0.0006758692,0.0002849083,0.001090295,0.0001611732,0.0007834416,0.00002111453,0.00003634809,0.0004849579,0.0001436639],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955105,0.0002711329,0.0000329358,0.001810753,0.0007050468,0.001335511,0.00001777964,0.00001775846,0.0002986267],"genre_scores_gemma":[0.9923044,0.005298836,0.0006994653,0.0003737918,0.001156357,0.00001777922,0.00002709886,0.00004737554,0.00007485921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07480637,"threshold_uncertainty_score":0.9990174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294594451113258,"score_gpt":0.397294345372739,"score_spread":0.3643484008616064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}